Title : Different approaches to Design and evaluation of anti Inflammatory colon specific Drug delivery systems

Type of Material: Thesis
Title: Different approaches to Design and evaluation of anti Inflammatory colon specific Drug delivery systems
Researcher: Vemula, Sateesh Kumar
Guide: Reddy, V Prabhakar
Department: Faculty of Pharmaceutical Sciences
Publisher: Jawaharlal Nehru Technological University, Hyderabad
Place: Hyderabad
Year: 2013
Language: English
Subject: Design
Evaluation
Inflammatory
Systems
Medical Sciences
Medical and Health Sciences
Dissertation/Thesis Note: PhD; Faculty of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Hyderabad, Hyderabad; 2013
Fulltext: Shodhganga

00000000ntm a2200000ua 4500
001453827
003IN-AhILN
0052024-06-27 17:23:48
008__240627t2013||||ii#||||g|m||||||||||eng||
035__|a(IN-AhILN)th_453827
040__|aJNTU_500028|dIN-AhILN
041__|aeng
100__|aVemula, Sateesh Kumar|eResearcher
110__|aFaculty of Pharmaceutical Sciences|bJawaharlal Nehru Technological University, Hyderabad|dHyderabad|ein|0U-0017
245__|aDifferent approaches to Design and evaluation of anti Inflammatory colon specific Drug delivery systems
260__|aHyderabad|bJawaharlal Nehru Technological University, Hyderabad|c2013
300__|a219 p.|c-
500__|aBiblography p. 200-219
502__|bPhD|d2013|cFaculty of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Hyderabad, Hyderabad
520__|aThe intent of current investigation is to make colon targeting newlineflurbiprofen and ketorolac tromethamine matrix and compression coated newlinetablets using time dependent hydroxypropyl methylcellulose, sodium newlinealginate and pH sensitive Eudragit S100 that retard the liberation of drug in upper gastro intestinal system and also show progressive release in colon. The prepared formulations were optimized using dissolution newlinetests and evaluated for colonic delivery by x-ray imaging and pharmacokinetic studies in healthy humans. The optimized formulation newlineof flurbiprofen and ketorolac tromethamine showed 7.26±0.05 % and 6.75±0.49% (negligible release) in the initial lag period of 5 h followed by progressive release up to 99.27±0.46 % and 97.47±0.93% for 24 h newlinerespectively. The x-ray imaging study in human volunteers illustrated that the tablets arrived to colon with no loss of integrity in the upper gastrointestinal tract. Cmax of colon targeted compression coated tablets newlinewa
650__|aMedical Sciences|2UGC
650__|aMedical and Health Sciences|2AIU
653__|aDesign
653__|aEvaluation
653__|aInflammatory
653__|aSystems
700__|aReddy, V Prabhakar|eGuide
856__|uhttp://shodhganga.inflibnet.ac.in/handle/10603/18969|yShodhganga
905__|afromsg

User Feedback Comes Under This section.